249 related articles for article (PubMed ID: 37343363)
1. Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice.
Kang X; Ng SK; Liu C; Lin Y; Zhou Y; Kwong TNY; Ni Y; Lam TYT; Wu WKK; Wei H; Sung JJY; Yu J; Wong SH
EBioMedicine; 2023 Jul; 93():104670. PubMed ID: 37343363
[TBL] [Abstract][Full Text] [Related]
2. Gavage of Fecal Samples From Patients With Colorectal CancerĀ Promotes Intestinal Carcinogenesis in Germ-Free andĀ Conventional Mice.
Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
[TBL] [Abstract][Full Text] [Related]
3. High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites.
Yang J; Wei H; Zhou Y; Szeto CH; Li C; Lin Y; Coker OO; Lau HCH; Chan AWH; Sung JJY; Yu J
Gastroenterology; 2022 Jan; 162(1):135-149.e2. PubMed ID: 34461052
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects.
Zhao R; Coker OO; Wu J; Zhou Y; Zhao L; Nakatsu G; Bian X; Wei H; Chan AWH; Sung JJY; Chan FKL; El-Omar E; Yu J
Gastroenterology; 2020 Sep; 159(3):969-983.e4. PubMed ID: 32387495
[TBL] [Abstract][Full Text] [Related]
5. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
6. High Soluble Fiber Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites in Mice.
Yang J; Wei H; Lin Y; Chu ESH; Zhou Y; Gou H; Guo S; Lau HCH; Cheung AHK; Chen H; To KF; Sung JJY; Wang Y; Yu J
Gastroenterology; 2024 Feb; 166(2):323-337.e7. PubMed ID: 37858797
[TBL] [Abstract][Full Text] [Related]
7. Changes in Microbial Community Composition Related to Sex and Colon Cancer by Nrf2 Knockout.
Song CH; Kim N; Nam RH; Choi SI; Yu JE; Nho H; Surh YJ
Front Cell Infect Microbiol; 2021; 11():636808. PubMed ID: 34249773
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota transplanted from old mice promotes more colonic inflammation, proliferation, and tumor formation in azoxymethane-treated A/J mice than microbiota originating from young mice.
Crossland NA; Beck S; Tan WY; Lo M; Mason JB; Zhang C; Guo W; Crott JW
Gut Microbes; 2023 Dec; 15(2):2288187. PubMed ID: 38031252
[TBL] [Abstract][Full Text] [Related]
9. Traditional Medicine Pien Tze Huang Suppresses Colorectal Tumorigenesis Through Restoring Gut Microbiota and Metabolites.
Gou H; Su H; Liu D; Wong CC; Shang H; Fang Y; Zeng X; Chen H; Li Y; Huang Z; Fan M; Wei C; Wang X; Zhang X; Li X; Yu J
Gastroenterology; 2023 Dec; 165(6):1404-1419. PubMed ID: 37704113
[TBL] [Abstract][Full Text] [Related]
10. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
Front Immunol; 2020; 11():588079. PubMed ID: 33072135
[TBL] [Abstract][Full Text] [Related]
11. YYFZBJS ameliorates colorectal cancer progression in Apc
Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
[TBL] [Abstract][Full Text] [Related]
12. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
[TBL] [Abstract][Full Text] [Related]
13. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apc
Li L; Li X; Zhong W; Yang M; Xu M; Sun Y; Ma J; Liu T; Song X; Dong W; Liu X; Chen Y; Liu Y; Abla Z; Liu W; Wang B; Jiang K; Cao H
EBioMedicine; 2019 Oct; 48():301-315. PubMed ID: 31594750
[TBL] [Abstract][Full Text] [Related]
15. Male-Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer Development.
Wang L; Tu YX; Chen L; Zhang Y; Pan XL; Yang SQ; Zhang SJ; Li SH; Yu KC; Song S; Xu HL; Yin ZC; Yue JQ; Ni QL; Tang T; Zhang JL; Guo M; Zhang S; Yao F; Liang XJ; Chen ZX
Adv Sci (Weinh); 2023 Sep; 10(25):e2206238. PubMed ID: 37400423
[TBL] [Abstract][Full Text] [Related]
16. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q
Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876
[TBL] [Abstract][Full Text] [Related]
17. Gender-based effect of absence of gut microbiota on the protective efficacy of Bifidobacterium longum-fermented rice bran diet against inflammation-associated colon tumorigenesis.
Kumar R; Maurya AK; Parker KD; Kant R; Ibrahim H; Kabir MI; Kumar D; Weber AM; Agarwal R; Kuhn KA; Ryan EP; Raina K
Mol Carcinog; 2022 Oct; 61(10):941-957. PubMed ID: 35856887
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites.
Bai X; Wei H; Liu W; Coker OO; Gou H; Liu C; Zhao L; Li C; Zhou Y; Wang G; Kang W; Ng EK; Yu J
Gut; 2022 Dec; 71(12):2439-2450. PubMed ID: 35387878
[TBL] [Abstract][Full Text] [Related]
19.
Zhang L; Ji Q; Chen Q; Wei Z; Liu S; Zhang L; Zhang Y; Li Z; Liu H; Sui H
Int J Biol Sci; 2023; 19(14):4393-4410. PubMed ID: 37781044
[No Abstract] [Full Text] [Related]
20. AC1Q3QWB inhibits colorectal cancer progression by modulating the immune response and balancing the structure of the intestinal microbiota.
Zhu W; Li J; Chen Y; Liu Z; Zhang Q; Kang C
Int Immunopharmacol; 2023 Mar; 116():109768. PubMed ID: 36731153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]